As Asia undergoes a profound demographic transformation, the life insurance industry stands at a pivotal juncture. The region is aging faster than any other in the world – a trend that is reshaping societies, healthcare systems and consumer needs. Life insurers face an urgent imperative: to evolve in lockstep with this shift and bridge the growing protection gap among elderly populations.
While the industry has made commendable strides, the journey is far from complete. Rising life expectancy and falling birth rates are fundamentally altering the risk landscape, requiring insurers to rethink traditional underwriting models, develop accessible products, and foster collaboration across public and private sectors. This article explores the demographic data driving these changes, highlights emerging healthcare risks, and outlines pragmatic solutions to increase insurance accessibility for the elderly.
Asia’s population aged 65 and older is projected to surge from 414 million in 2020 to 1.2 billion by 2060. This means that one in four people across the region will be elderly – a statistic that carries profound implications for every aspect of social and economic planning.
According to UN criteria, a country is considered “aging” when 7% of its population is over 65, “aged” at 14%, and “super-aged” when that figure surpasses 21%. If the trend across Asia continues, some countries will see an average 35-40% of their population at 65 years or above by 2050 – well beyond the UN threshold for “super-aged”. (Figure 1).
Population Trends Across Asia
| Market | Mean Age (2020) | Fertility Rate | Life Expectancy | 65+ Population (2020) | 65+ (2050 Forecast) | |
| Japan | 48 | 1.29 | 84.6 | 29.6% | 37.5% | |
| Republic of Korea | 42.8 | 0.88 | 83.6 | 15.8% | 39.4% | |
| Singapore | 41.2 | 0.99 | 82.8 | 13.2% | 34.2% | |
| Hong Kong | 44.3 | 0.87 | 85.1 | 18.8% | 40.6% |
Figure 1: Aging in Asia and the Pacific. Source: ESCAP 2022, https://www.population-trends-asiapacific.org/data/HKG
With aging comes a higher incidence of chronic diseases that threaten both longevity and quality of life. Aging is now the leading risk factor for conditions such as diabetes, cardiovascular disease, various cancers, osteoporosis, respiratory diseases, and dementia.
Recent data underscores the growing burden of chronic diseases among aging populations, underscoring the urgency for more effective healthcare strategies. In Singapore, the National Population Health Survey of 2020[1] revealed significant increases in key conditions among older adults: hypertension rose by 45.8% (from 24.2% in 2017 to 35% in 2020), diabetes by 7.9% (from 8.8% to 9.5%) and lipid disorders by 10% (from 35.5% to 39.1%). Similarly, Hong Kong’s Blueprint for primary healthcare[2] identifies the management of chronic diseases in the elderly as a major challenge, with aging populations placing increasing pressure on health and social care systems. In 2020/21, 31% of Hong Kong residents – approximately 2.2 million people – reported having at least one chronic condition, nearly half of whom were aged 65 and above. This proportion is expected to rise significantly in the coming decade, with hypertension and diabetes mellitus being the most prevalent among the elderly.
We now understand that many chronic diseases are strongly linked to modifiable lifestyle factors such as smoking, physical inactivity, poor diet, and lack of social engagement. In other words, maintaining a healthy lifestyle can significantly delay the onset of frailty, disability, and dementia.
This presents a clear opportunity for insurers to evolve beyond their traditional reactive role – providing payments and services after health events – toward becoming proactive partners in promoting overall well-being and lifestyle management. By helping prevent health events or mitigate their impact, insurers can play a more meaningful role in long-term health outcomes.
The industry has begun to recognize this shift, experimenting with a range of initiatives. Some insurers have engaged in public-private partnerships, such as the U.S. National Diabetes Prevention Program (National DPP), offering covered benefit to individuals at high risk of type 2 diabetes. These programs typically include education on nutrition, physical activity, stress management, and problem-solving.[3]
Most insurers, however, are launching initiatives within their ecosystems. While some remain reactive – limiting lifestyle modification support to coverage for preventative screenings, specialist visits, and medications – others are taking a more active role. These insurers are introducing digital tools like mobile apps and online platforms that offer healthy living tips, exercise programs, and mindfulness resources, often incentivized through rewards.
A small number of insurers are going further, integrating health, wellness, and technology into a comprehensive ecosystem. These offerings may include telemedicine, AI-powered symptom checkers, wearable devices, and partnerships with health-focused brands. Some even provide enhanced services such as concierge care or dedicated relationship managers to guide policyholders in their lifestyle management journey.
In select markets, insurers have also explored risk-based pricing, charging higher premiums for higher-risk lifestyles or offering discounts for participation in wellness programs – to quit smoking, for example – to encourage healthier behaviors.
Governments in Asia have been proactive in building healthcare systems to support aging populations. Countries like Japan, South Korea, Taiwan, and Mainland China have implemented universal healthcare coverage with a focus on cost control and preventive care. Hong Kong operates a dual-track system, offering both near-free public care and a competitive private healthcare market (Figure 2).
Overview of Health Systems by Market
| Category | Japan | South Korea | Mainland China | Taiwan | Hong Kong | |
| Universal Coverage | Yes | Yes | Yes | Yes | Yes | |
| Population Coverage | 100% | 100% | 100% | Nearly 100% | 100% | |
| Funding Source | Employers, employees (salaried); government (others) | Employers, employees (salaried); government (others) | Employers, employees (salaried); government (others) | Employers, employees (salaried); government (others) | Fully funded by government through general taxation | |
| Copayment Requirements | 10–30%, varies by age and service | 5–60%, varies by age and service; out-of-pocket caps apply | 10–30%, varies by age and service | Fixed 6.5% of cost; safety net for low-income groups | Fixed HKD 120 (USD 15) per inpatient day | |
| Freedom to Choose Providers | Yes | Yes | Restricted for GPs; choice for specialists | Yes | Yes | |
| Preventive Care for Aging Populations | Yes | Yes | Limited (some vaccines, few screenings for 60+) | Yes | Yes | |
| Cost Control Measures | Fee schedules, drug price controls, co-payments, emphasis on prevention | Fee schedules, cost-sharing, prevention-focused policies | Drug price negotiation, provider utilization controls | Regulated fee structures, utilization management | Limited cost control initiatives |
Figure 2: Presentation for the Asia Insurance Medical Association Conference 2025. Source: PartnerRe
While coverage is nearly universal across these economies, health systems differ in copayment models, funding mechanisms and access to preventive services. Despite these efforts, several persistent challenges remain: escalating social security costs, fragmented care delivery, insufficient healthcare workers, uneven rural-urban access, and suboptimal public health campaigns.
These limitations highlight the expanding role of commercial insurance in supporting the elderly. Private insurers are increasingly stepping in with supplementary coverages such as long-term care coverage, nursing benefits, critical illness products and caregiver income support.
For example, Singapore’s MedShield Life and CareShield are national schemes that work alongside employer-sponsored and private insurance to help close coverage gaps. In Japan and South Korea, nursing and caregiver benefits are commonly offered to offset service shortfalls and copayment burdens. In contrast, Hong Kong lacks a government-backed insurance framework tailored for seniors. As a result, public awareness and uptake of senior-specific insurance products remain low. To adapt, insurers often incorporate senior-specific health disorders or requirements into regular products such as critical illness or standard medical products available across age groups.
Yet even with emerging products, accessibility remains a critical hurdle—particularly in the underwriting process. Current insurance products often aim to serve multigenerational customers, but many of them are not designed with the elderly in mind. As people age, their burden of chronic disease increases, complicating the underwriting process and disqualifying many from coverage under standard terms.
A key reason for this is co-morbidity—the presence of two or more chronic conditions. In individuals over 65, co-morbidity prevalence rises sharply. In a study on the epidemiologic characteristics and sociodemographic factors associated with multimorbidity in Singapore, the percentage of co-morbidity increased from 20% in the < 50 age group to 50% and 80% in age groups 50-64 and 65–79 years respectively (Figure 3). Co-morbidity leads to higher disclosure rates, more medical evidence requests, and longer, more unpredictable application processes.
Prevalence of Multi-morbidity by Sex and Age Group
Figure 3: Epidemiologic Characteristics of Multimorbidity and Sociodemographic Factors Associated With Multimorbidity in a Rapidly Aging Asian Country, JAMA 2019. Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC6902794/
Compounding this is the rise of incidental medical findings due to preventive screenings. In a study conducted by a major diagnostic provider in China, over 57% of individuals aged 35–60 undergoing health checks were found to have lung nodules, while 15% showed signs of coronary artery disease. Although not all findings have immediate health impacts, they often trigger extended underwriting scrutiny, leading to medical evidence requirements, delays and diminished customer experience.
The complexity of modern insurance products – covering multiple organ systems, physical and mental impairments, congenital conditions, and a broad array of treatments – further adds to underwriting challenges. Standard automation can handle simple disclosures, but many age-related impairments require nuanced interpretation, which current digital tools often lack.
To improve access for older customers while maintaining risk quality, we propose four potential underwriting solutions grounded in product design, behavioral science, and clinical insights.
Simplifying underwriting for elderly-focused products begins with rethinking product design. Numerous surveys have consistently shown that seniors are less concerned with comprehensive coverage and more interested in whether a product addresses their specific, high-priority needs – such as chronic conditions, hospitalisation support, and long-term care triggers.
Rather than building overly broad products that attempt to cover every eventuality, insurers can target a focused set of conditions. The underwriting process then shifts from exhaustive disclosure to identifying a small subset of high-risk individuals within a broader low-risk population. For those at lower risk, underwriting can be dramatically streamlined and pricing calibrated accordingly. This not only simplifies the journey for applicants but also helps build trust and transparency in the application process.
Waiting periods are a common tool explored by insurers to reduce or simplify waiting periods. This is an important tool to address underwriting concerns provided the waiting periods are appropriate.
Short waiting periods (e.g. 30–90 days) offer limited help in reducing underwriting complexity. For instance, Alzheimer’s typically progresses slowly, making early identification difficult during short windows (Figure 4).
Progression from Mild Cognitive Impairment to Dementia of Alzheimer’s Disease
Figure 4: Charting the Course from Healthy Aging to AD. MCI: mild cognitive impairment; AD: Alzheimer’s disease. Source: National Institute On Aging – NIH
Similarly, cancer diagnoses often take several months: a large-scale claims study of nearly 460,000 cancer patients showed an average diagnostic timeline of over 150 days, with more than 15% diagnosed after 180 days. Another breast cancer study found a median 150-day gap between symptom detection and treatment.
If a product includes an appropriate waiting period of 6 to 12 months for a cancer product, many of the high-risk individuals will self-select out or become diagnosable within that window—without the need for intrusive underwriting at entry. This allows insurers to safely reduce disclosure requirements, limit testing, and open the door to automated or near-automated issuance. The result is a product that is more accessible, faster to issue, and more transparent for seniors—without compromising risk management.
One of the key challenges in underwriting for aging populations is the high prevalence of chronic conditions as seen earlier. Traditional approaches often rely heavily on medical evidence, as eliciting complex medical information through questions can be difficult, especially for older applicants. In some cases, insurers avoid asking questions altogether and instead price products for impaired lives. This can make underwriting feel like a barrier to sales, or lead to expensive products and increased risk exposure.
A promising alternative lies in rethinking how questions are designed. Instead of relying on complex medical terminology or expecting applicants to interpret clinical evidence, insurers can use clinical pathways to identify simple, understandable triggers that act as proxies for risk. For example, instead of asking applicants to interpret pathology reports for colorectal polyps, a more effective question might be: “What follow-up interval was recommended by your doctor?” This approach improves clarity, reduces the risk of misrepresentation, and can support more efficient claims adjudication.
Clear, behaviorally sensitive question design should be supported by underwriting frameworks that reduce adverse selection – such as aligning sum assured with financial need, applying criticality thresholds and excluding for pre-existing conditions where appropriate. Together, these tools help balance both the intent and impact of customer disclosures.
Simplifying underwriting is just one part of the puzzle. Enabling it with robust levers for enhanced customer experience such as avoiding lump-sum payments for minor conditions, ensuring payouts are proportionate to hardship, and preventing windfall gains that may distort incentives.
Supporting healthy aging through post-issue risk management is essential for the long-term sustainability of senior-focused insurance products. Underwriting shouldn’t end at policy issuance. Instead, insurers can embed post-issue strategies – such as preventive health screenings, wellness programs, and regular medical check-ins – to actively manage risk while promoting healthier lifestyles. These initiatives also foster ongoing engagement and improve retention.
Such strategies are modular and adaptable, depending on the product’s goals and market context. We welcome the opportunity to collaborate with insurance partners to tailor these approaches in ways that balances access, simplicity, and sustainability.
Insurers have a unique opportunity to add value post-issuance through wellness services, preventive screenings, and digital health engagement tailored to seniors. Offerings could include access to virtual GP consultations, nurse helplines, medication delivery, dietary coaching, and even non-medical assistance such as transportation or home safety upgrades. Family caregivers—an often-overlooked part of the care chain—can also be engaged through educational resources and care coordination tools.
While wellness programs have faced scepticism due to limited tailoring to specific age groups, lack of financial support, and unclear impact on claims experience, emerging data shows promise. For example, analysis of the U.S. National Diabetes Prevention Program (National DPP) indicates that insurance coverage improves affordability and accessibility, leading to higher enrolment and participation rates.
A 2019 study of Vitality’s Active Rewards program found significant increases in physical activity across all policyholder participant groups:
Despite lingering doubts, it’s important to continue investing in healthy aging ecosystems. These initiatives not only improve customer satisfaction and brand loyalty, but also proactively manage risk, reduce claims, and extend healthy life expectancy – ensuring the long-term viability of senior products.
The rise of the aging society represents one of the most complex and pressing challenges for insurers in Asia. Bridging the protection gap requires far more than just new products—it demands a holistic strategy that integrates underwriting, pricing, digital solutions, and service design.
No single stakeholder can address this challenge alone. Success will come through partnerships – between insurers and public institutions, with families and caregivers, and across a wide range of digital and healthcare vendors. When these players come together, the result can be a more resilient, inclusive insurance landscape—one that empowers seniors to age with confidence and dignity.
Contact Us
At PartnerRe, we’re committed to supporting our clients across APAC in designing solutions tailored to the unique needs of aging societies. Find out more about our partnership services and get in touch with our team.
Contributor
Dr. Dipali Jawalkar, Head of Medical Underwriting & Claims, APAC Life & Health
References
[1] Singapore Department of Statistics | Statistics Singapore Newsletter Issue 1, 2022 – Key Highlights from the National Population Health Survey 2020
[2] https://www.primaryhealthcare.gov.hk/bp/en/blueprint-2/
[3] https://www.cdc.gov/diabetes-prevention/programs/what-is-the-national-dpp.html